2 The participants will be followed up at 12 months, 24 months, 30 months or 36 months after the date of recruitment.
3 We follow up knee OA progression to analyse progression risk factors of knee OA and develop progression risk assessment model whose prediction ability is verified by both internal validation and external validation.
4 Exposure measures (including demographic variables, risk factors and intervention factors) and special measures (including functional MRI, biomarker and gait analysis) are both used to analyse progression risk factors of knee OA. 5 The follow time and sample size of this study design may be not enough for establishing a progression model, and we plan to continue to enroll new patients after 3 years limitation to expand the database and improve the progression model. In conclusion, it is of great importance to set up a cohort of knee OA, follow up the progression of knee OA, analyse related risk factors and finally develop a predicting model, for that would be meaningful to early prevention of knee OA. Objectives 1. Develop a cohort of knee OA patients, collect baseline information and follow up knee OA progression 2. Analyse progression risk factors of knee OA, develop progression risk assessment model 3. Verify risk prediction ability of the model, use both internal validation and external validation
METHODS AND ANALYSIS Study design
This study is a multicentre, prospective cohort study of people living in Beijing with knee OA at early stages, sponsored by the Beijing Municipal Science &Technology Commission, located in Beijing, China. There are 5 clinical centres participating the study, including Peking University Third Hospital, Peking University First Hospital, Peking University People's Hospital, Beijing Friendship Hospital and China-Japan Friendship Hospital. Sample size estimate
The proportion of knee arthritis progression during the study was assumed to be 15% based on literature reports, and there are 16 predictive factors included in, which were confirmed by most of the studies. According to the multivariable Logistic regression model sample size estimation method,16×15= 240 cases of knee OA progression are needed, so the total number of cohorts by final follow up should be 240÷15%=1600 cases. Considering the possibilities of loss of follow-up, the sample size was expanded to 1.2 times. Therefore, the estimated sample size is 2000 cases.
Study population
Recruitment of a baseline cohort of 2000 participants will be conducted between December 2017 and November 2018. The participants will be followed up at 12 months,24 months, 30 months or 36 months(see table 1) after the date of recruitment. will be recorded, and the knee adduction moment (KAM) will be calculated to assess medial compartment load. Gait analysis will be carried out in the orthopedic laboratory of Peking University Third Hospital.
Outcome measures Patients will be monitored through follow-up in the researching hospitals. The primary outcome measure of this subject is a comprehensive outcome index, which will be combined with clinical WOMAC score and imaging K-L grade, and clinical outcomes, that is, whether the patient receives surgical intervention during the follow-up period.
The WOMAC score will be evaluated by questionnaire. BIt is the Osteoarthritis Index of Western Ontario and McMaster University, including 5 questions concerned with pain, 2 questions related to joint stiffness and 17 questions about difficulties with completing daily activities. Each question contains five grades (0=none, 4=severe), so the score range is 0-20 points for pain, 0-8 points for stiffness, and 0-96 points for daily living ability. The higher the WOMAC score, the worse the corresponding state.
All of the participants will get a X-ray examination of the knee joint (anteroposterior and lateral film), and will be filmed at knee extension weight-bearing position. This study will use the same KL classification as Beijing Osteoarthritis Study 23, 24 (Kellgren and Lawrence et al. 25 proposed in 1957, KL classification ≥ 2 is defined as imaging osteoarthritis) criteria to define patellofemoral imaging bone Arthritis, the grading standards are as follows:
Grade 0: no radiographic features of OA are present Grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping Grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph Grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity Grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity The outcome indicator for this study is knee OA progression, which is defined as any of the following three at the 30-month follow-up point:
1 More than 2 score items of WOMAC score progress in one follow-up period (12 months); 2 K-L graded follow-up period was ≥1 grade compared with baseline; 3 Surgical intervention (arthroscopy, osteotomy, single ankle replacement, patellofemoral joint replacement or total knee arthroplasty).
Study protocol
The study protocol consists of three main steps: screening and enrollment, baseline visit, and follow-up visits.
Screening and enrollment
The screening of potential participants will be conducted by orthopaedic surgeon at each clinical center to assess the eligibility for the study according to the inclusion and exclusion criteria. When eligible, subjects will be informed to participate a meeting in the hospital. During the meeting, they will receive a common version of the study protocol which also contains answers to common questions, and they will also be verbally informed by trained research personnel, regarding the nature and purpose of the study, their rights to quit the study Page 6 of 12 For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y at any time, and given time to decide whether or not to participate. After that, study participants will be required to sign a written informed consent.
Baseline visit
Once the written informed consent is obtained, the following information or examine data will be obtained: The study will develop relevant case report form( CRF) based on the research plan. And the researchers will load the data into the case report form in a timely, complete and accurate manner based on the original observation records of the research subjects. Then the questionnaire will be reviewed and signed by an audit team and sent to the clinical research data administrator in time. The entry will be done by two administrator using two computers independently, and the data will be compared twice. Problems found during the entry or comparison will be notified to the inspector in time, and the researcher will be asked to explain. Questions and answers should be in the form of a question form, which should be kept for future reference.
Data verification and management After all case report forms are double-entry and verified, the data manager will write a database check report, which includes the completion of the study (including the list of shedding), the inclusion/exclusion criteria, the integrity inspection, the logical consistency inspection, outlier data inspection, time window inspection, intervention inspection, adverse event inspection, etc.
At the review meeting, the main investigator, the representative of the collaboration unit, the inspector, the data administrator and the statistician will decide on the issues raised in the informed consent form and the database inspection report, and write an audit report. The database will be locked at the same time.
Data archiving 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y After data entry and verification of the case report form are completed as required, CRF will be archived in the order of number for verification. Electronic data files include databases, inspection programs, analysis programs, analysis results, codebooks and documentation. They should be stored in separate categories, and multiple backups should be stored on different disks or recording media for safekeeping in case of loss or damage. All the original files should be kept for a period of time within the corresponding regulations.
Statistical Analysis The demographic characteristics, general conditions, risk factors of the disease, and intervention factors will be described by using the general statistical description method according to the distribution of the data. Nested case-control analysis will be performed, and the subjects will be divided into knee osteoarthritis progression group and non-progression group based on WOMAC score and imaging K-L grade. The differences of the demographic characteristics risk factors and intervention factors between the two groups will be compared. Several statistical methods will be used to establish the risk prediction model of knee osteoarthritis progression, including Logisitc regression model, discriminant analysis, classification decision tree, etc. And K-fold cross validation will be performed to select the best prediction model based on the C-index of these prediction models. The external validation will use the pre-established Knee Osteoarthritis Cohort data to determine the accuracy of the established model.
PATIENT AND PUBLIC INVOLVEMENT
Patients were not involved in the development of research questions, design, recruitment or conduct of this study. Results of this study will be available through publication in peer-reviewed journals and at national or international conferences. Besides, the results will be disseminated to all participants via "group chat" of the social software "WeChat".
DISCUSSION
The study is going to establish a study cohort of knee osteoarthritis, follow-up the progress of knee osteoarthritis and analyze the relevant risk factors, so as to establish a predictive model to predict its progress and outcome, which is of great value and positive for the early prevention and treatment of knee OA. By now, the research on the progress of knee osteoarthritis has revealed the influencing factors of the progress of knee osteoarthritis, but the importance of each influencing factor is still unclear. We still cannot evaluate the progressing risk based on the patient's lifestyle and living environment. The risk of progress cannot be targeted to preventive interventions. By constructing a progression model, we can calculate the risk of osteoarthritis progression for each patient, evaluate the contribution of each factor to the progression of osteoarthritis in patients, take targeted interventions for highrisk patients, and adopt appropriate weight loss treatments, exercise therapy, Chinese medicine treatment, etc.
At present, there is still a lack of mature and generally acknowledged risk prediction model for knee osteoarthritis. The arthritis progression model study proposed by Zhang et al. 5 in 2011 was based on 99 cases and 179 control groups. However, the scale of the study is relatively small, and the model's ability to go through external validation is poor (AUC=0.52). And the model fails to assess the risk of biomarker or cartilage function, and lacks to predict the progress of knee OA on mechanism level.
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In order to improve the sensitivity of the study, we will carry out the following research design. On the one hand, we will use functional MRI, biological markers and gait analysis as secondary outcome indicators. Functional MRI will serve as a model observation index with good sensitivity and specificity, because it allows direct observation and evaluation toward articular cartilage-the most fundamental pathological structure of osteoarthritis; the detection of related molecular biological markers (type II collagen C-terminal peptide, u-CTX-II) and three-dimensional gait analysis help observe the progress of osteoarthritis from molecular biology and biomechanics angle, thus, they not only have the theoretical advantage of early and accurate assessment of the development of osteoarthritis, but also are of great significance for the further exploration of relevant mechanisms in the future. On the other hand, this study intends to combine the WOMAC score, the imaging KL grades and the clinical outcome to observe knee OA progression. This comprehensive outcome index is expected to improve the sensitivity of the model within a limited follow-up time.
The limitations of this study are as follows: 1. Short study time: the duration of this study is limited at 3 years because of the project requirements, it might be difficult to observe obvious progression of OA within this limited time. 2. Insufficient sample size: The sample size of this study design is only 2000, which is relatively small for establishing a progression model. In response to these two limitations, we will use unique statistical methods and outcome indicators to improve the accuracy and sensitivity of the research. Besides, we plan to continue to enroll new patients after 3 years limitation to expand the database and improve the progression model. 3. The subjects enrolled in this study are permanent residents of Beijing, excluding the rural population. In order to improve the universality of the model, we will use external data including 1294 rural populations for external verification, and choose to establish models for both urban and rural people or perform classification modeling according to results. [J] . Ann Rheum Dis, 2011, 70(9) : 1599-1604. [J] . Am J Cardiol, 1993, 72 [J] . Eur J Epidemiol, 2011, 26(8) [J] . J Interv Cardiol, 1994, 7(6) : 557-564. [9] Kip K E, Hollabaugh K, Marroquin O C, et al. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention [J] . J Am Coll Cardiol, 2008, 51(7) : 701-707. [12] Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians [J] . J Gen Intern Med, 2003, 18(12) : 1039-1052.
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ABSTRACT Introduction
Millions of patients are currently suffering from pain and dysfunction caused by osteoarthritis, and billions of dollars have been put into medical treatment. But because there's no effective treatment that can reverse the progression of knee OA, it's of great importance to find the risk factors that may influence or predict the progression. However, although there're many studies researching risk factors of the progression, there's few focusing on the impact of each risk factor or predicting progression of knee OA. This study aims to develop a cohort of primary knee OA patients in Beijing area and establish models to identify influence of each risk factors that may predict knee OA progression.
Methods and analysis
This is a prospective, multicenter, hospital based cohort study. The study population comprises 2000 patients with primary knee OA from Beijing area. The recruitment and baseline visits started at December 2017 and will finish in November 2018.After baseline visits, these patients will be followed for 3 years or until the occurrence of primary outcomes. Demographic variables, such as age at diagnosis will be collected during baseline visit. Influencing factors including occupational exposures, family history, treatment and so on will be collected in baseline and each follow-up visit. The primary outcome measure is a comprehensive outcome index, which will be combined with clinical WOMAC score and imaging K-L grade, and clinical outcomes. These data will also be collected in baseline and each follow-up visit.
Ethics and dissemination
This study protocol has been approved by Peking University Third Hospital Medical Science Research Ethics Committee. All the participants gave written informed consent. The findings will be published in peer-reviewed journals and presented at national or international conferences. Besides, the results will be disseminated to all participants via the social software "WeChat".
Trial registration number
ChiCTR-ROC-17013790; Pre-results
STRENGTHS AND LIMITATIONS OF THIS STUDY
1 We develop a multicentre cohort of primary knee OA patients targeting at 2000 participants.
2 The participants will be followed up at 12 months, 24 months, 30 months or 36 months after the date of recruitment. 4 Exposure measures (including demographic variables, risk factors and intervention factors) and special measures (including functional MRI, biomarker and gait analysis) are both used to analyse progression risk factors of primary knee OA.
5 The follow time and sample size of this study design may be not enough for establishing a progression model, and we plan to continue to enroll new patients after 3 years limitation to expand the database and improve the progression model.
INTRODUCTION
Osteoarthritis (OA), also called degenerative osteoarthropathy, may severely influence patients' quality of life. It can cause serious local pain, deprive joint functions and eventually lead to disabilities, which brings huge medical and economical burden to our society which is suffering from an aging population. Research shows there was 9,300,000 patients suffering from symptomatic knee OA in the United States in 2005, and the global age-standardised prevalence of knee OA was 3.8% in 2010. 1,2 In China, the overall prevalence of symptomatic knee OA was as high as 8.1% in 2012. 3 By now, there is no effective treatment which can reverse progression of knee OA. 4 Meanwhile, adverse reaction from symptomatic treatment and high cost and surgical risks from knee replacement make it hard to balance the cost and benefit in knee OA treatment. 5 Under this circumstance, if it is possible to restrain knee OA within early stages, there would be great improvement in prognosis and great economization in both medical and economical resources. To accomplish that, we need to analyse the risk factors of knee OA progression, and make specific and targeted efforts in prevention.
The risk factors of OA has been studied extensively and deeply, various factors including age, gene, sexuality, hormone, biomechanics and local microenvironment appear to have explicit relevance with the occurrence of OA. The progression of OA is also influenced by various factors. Generally, systematic factors including age, race and heredity increase susceptibility of OA and local factors including weight, biomechanics and local microenvironment accelerate progression of OA. In a word, synergistic effect of systematic factors and local factors is the cause of OA progression.
However, although study about progression of knee OA is emerging one after another, there is still not enough study focusing on the impact of each risk factor or predicting progression of primary knee OA. To our knowledge, the first accepted model of knee OA progression risk factors is developed by Zhang et al. at 2011, 6 and there is no large scale cohort study or database in China as we find no related study or work on database foundation from searching in Medline, Embase, SCI, CINAHL, BIOSIS, Cochrane database, CNKI and Wanfang database. In contrast, the foundation of large scale database has already gained remarkable achievement in preventive treatment in neurological disease, tumor, endocrine disease and cardiovascular disease. [7] [8] [9] [10] [11] [12] [13] [14] Moreover, assessment of prevention and treatment techniques made by large-scale database may have a decided impact on health economic policy. 15 
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Study population
Recruitment of a baseline cohort of 2000 participants will be conducted between December 2017 and November 2018. The participants will be followed up at 12 months,24 months, 30 months or 36 months(see table 1) after the date of recruitment. 0 (2017-5-20) ] which is registered on the Chinese Clinical Trial Registry (http://www.chictr.org.cn/index.aspx) under number ChiCTR-ROC-17013790.The study will be conducted in accordance with the principles of the Declaration of Helsinki (2013 version).Written informed consent will be obtained from study participants and all collected information will be treated as confidential.
Measures Exposure measures
The exposures of interest include demographic variables, risk factors and intervention factors. Demographic variables contain age at diagnosis, gender, height, weight and ethnicity. Risk factors contain occupational exposures (eg, physical labor, knee-lifting weight-bearing exercise, prolonged kneeling posture, etc.), family history, history of knee trauma, lower limb muscle strength (femoral quadriceps, adductor muscle, hamstring muscle strength) and female menopause. Interventional factors contain drug treatment (including analgesic drugs, nutrient cartilage drugs, anti-osteoporosis drugs), physical therapy, Chinese medicine treatment, exercise therapy and surgical treatment.
Special measures
This study will apply 3 new techniques to predict the progression of knee OA: functional MRI, [16] [17] [18] biomarker (CTX-II) [19] [20] [21] and gait analysis 22, 23 . These new techniques haven't been widely used in this area, but researches show they have great potential to be important predictors.
MR routine and functional image scans will be performed on knee osteoarthritis subjects included in Peking University Third Hospital and China-Japan Friendship Hospital. The scanning device used was a General Electric Company (GE, U.S.) MR scanner (field strength 3.0T). Routine scans include sagittal PDWI, T1WI, coronal PDWI and axial PDWI; functional imaging includes sagittal T2-mapping and T1ρ.The specific method is to postprocessing functional imaging to obtain pseudo-color map, observe the degree of cartilage damage in different areas, the region of interest (ROI) is delineated to measure the T2 value and the T1ρ value. The obtained knee cartilage measurements will be analyzed after the subjects completed all follow-up examinations.
In this study, the type II collagen C-terminal peptide (CTX-II), which is the most concerned type of cartilage conversion biomarker, was selected as the biological marker for detection to predict the progression of knee joint OA. Considering medical ethics requirements and research convenience, urine samples will be used for CTX-II analysis by enzyme-linked immunosorbent assay (ELISA). Centrifuge the patient's urine sample within 24 hours after receiving the urine sample, take 1-2ml of the supernatant, and collect it into the orthopedic clinical laboratory of Peking University First Hospital for ELISA kit measurement; if the sample cannot be delivered within 24 hours, it should be stored in a deep low temperature refrigerator until delivered.
The gait and related kinetic parameters of the subjects will be measured by using a threedimensional gait analyzer. The pace, step frequency and step size of the subjects will be observed, the duration of the lower limb support period and the percentage of support period will be recorded, and the knee adduction moment (KAM) will be calculated to assess medial compartment load. Gait analysis will be carried out in the orthopedic laboratory of Peking University Third Hospital. Outcome measures
Patients will be monitored through follow-up in the researching hospitals. The primary outcome measure of this subject is a comprehensive outcome index, which will be combined with clinical WOMAC score and imaging K-L grade, and clinical outcomes, that is, whether the patient receives surgical intervention during the follow-up period.
All of the participants will get a X-ray examination of the knee joint (anteroposterior and lateral film), and will be filmed at knee extension weight-bearing position. This study will use the same KL classification as Beijing Osteoarthritis Study 24, 25 (Kellgren and Lawrence et al. 26 proposed in 1957, KL classification ≥ 2 is defined as imaging osteoarthritis) criteria to define patellofemoral imaging bone Arthritis, the grading standards are as follows:
Study protocol
Screening and enrollment
The screening of potential participants will be conducted by orthopaedic surgeon at each clinical center to assess the eligibility for the study according to the inclusion and exclusion criteria. When eligible, subjects will be informed to participate a meeting in the hospital. During the meeting, they will receive a common version of the study protocol which also contains answers to common questions, and they will also be verbally informed by trained research personnel, regarding the nature and purpose of the study, their rights to quit the study The study will develop relevant case report form (CRF) based on the research plan. And the researchers will load the data into the case report form in a timely, complete and accurate manner based on the original observation records of the research subjects. Then the questionnaire will be reviewed and signed by an audit team and sent to the clinical research data administrator in time. The entry will be done by two administrator using two computers independently, and the data will be compared twice. Problems found during the entry or comparison will be notified to the inspector in time, and the researcher will be asked to explain. Questions and answers should be in the form of a question form, which should be kept for future reference.
Data archiving After data entry and verification of the case report form are completed as required, CRF will be archived in the order of number for verification. Electronic data files include databases, inspection programs, analysis programs, analysis results, codebooks and documentation. They should be stored in separate categories, and multiple backups should be stored on different disks or recording media for safekeeping in case of loss or damage. All the original files should be kept for a period of time within the corresponding regulations.
Quality control Standardized training was conducted for all participating surgeons and radiologist about filling in the case report form, physical examination, imaging examination and so on. In addition, all data was kept in certain documents and checked by research stuff in our team, to make sure all data are reliable.
PATIENT AND PUBLIC INVOLVEMENT
DISCUSSION
The study is going to establish a study cohort of knee osteoarthritis, follow-up the progress of knee osteoarthritis and analyze the relevant risk factors, so as to establish a predictive model to predict its progress and outcome, which is of great value and positive for the early prevention and treatment of primary knee OA. By now, the research on the progress of primary knee osteoarthritis has revealed the influencing factors of the progress of knee osteoarthritis, but the importance of each influencing factor is still unclear. We still cannot evaluate the progressing risk based on the patient's lifestyle and living environment. The risk of progress cannot be targeted to preventive interventions. By constructing a progression model, we can calculate the risk of osteoarthritis progression for each patient, evaluate the contribution of each factor to the progression of osteoarthritis in patients, take targeted interventions for high-risk patients, and adopt appropriate weight loss treatments, exercise therapy, Chinese medicine treatment, etc. At present, there is still a lack of mature and generally acknowledged risk prediction model for primary knee osteoarthritis. The arthritis progression model study proposed by Zhang et al. 5 in 2011 was based on 99 cases and 179 control groups. However, the scale of the study is relatively small, and the model's ability to go through external validation is poor (AUC=0.52). And the model fails to assess the risk of biomarker or cartilage function, and lacks to predict the progress of knee OA on mechanism level.
In order to improve the accuracy of the prediction model, we plan to use the classification decision tree, discriminant analysis and other methods to establish a prediction model, and use the K-fold cross-validation method to select the best prediction model. The original sample is randomly partitioned into k equal sized subsamples. Of the k subsamples, a single subsample is retained as the validation data for testing the model, and the remaining k-1 subsamples are used as training data. The cross-validation process is then repeated k times, with each of the k subsamples used exactly once as the validation data by comparing the Cindex between different prediction models, it is possible to select a more accurate prediction model. This method of cross-validation is a relatively mature and efficient, which is helpful to guide the selection of the optimal prediction model in this study. In addition, we will use an external cohort to validate our model. The database of 1,294 patients with knee osteoarthritis is established by Peking University People's Hospital in Zhaoquanying Town Health Center in Beijing.
The limitations of this study are as follows: 1. Short study time: the duration of this study is limited at 3 years because of the project requirements, it might be difficult to observe obvious progression of OA within this limited time. 2. Insufficient sample size: The sample size of this study design is only 2000, which is relatively small for establishing a progression model. In response to these two limitations, we will use unique statistical methods and outcome indicators to improve the accuracy and sensitivity of the research. Besides, we plan to continue to enroll new patients after three years limitation to expand the database and improve the progression model. 3. The subjects enrolled in this study are permanent residents of Beijing, excluding the rural population. In order to improve the universality of the model, we will use external data including 1294 rural populations for external verification, and choose to establish models for both urban and rural people or perform classification modeling according to results. 
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STRENGTHS AND LIMITATIONS OF THIS STUDY
 This study will establish the largest multicentre prospective cohort of patients with primary knee OA, targeting 2000 participants from Beijing, China.  Follow-up data will be collected at 12, 24, 30, and 36 months, depending on the date of recruitment for a total timeline of 36 months.  Exposure measures (including demographic variables, risk factors, and intervention factors) and special measures (including functional MRI, biomarkers, and gait analysis) will be used to analyse progression risk factors for primary knee OA.  The exposure and special measures collected will be analysed for their strength as progression risk factors in order to develop a validated risk assessment model.  Follow-up time and sample size may not be sufficient to establish and validate (both internally and externally) the risk assessment model.
INTRODUCTION
Osteoarthritis (OA), also called degenerative osteoarthropathy, may severely influence quality of life. It can cause serious localized pain, deprive joint functions, and eventually lead to disabilities. This leads to a huge medical and economic burden to society due to the increased proportion of the elderly population. Research shows there were 9 300 000 patients suffering from symptomatic knee OA in the United States in 2005 and the global agestandardised prevalence of knee OA was 3.8% in 2010. [1, 2] In China, the overall prevalence of symptomatic knee OA was as high as 8.1% in 2012. [3] Currently, there is no effective treatment which can reverse progression of knee OA. [4] Meanwhile, adverse reactions from symptomatic treatment, high costs, and surgical risks from knee replacement make it hard to balance the costs and benefits of knee OA treatment. [5] Under these circumstances, it would be ideal to restrain knee OA within the early stages to improve prognosis and reduce the burden on both medical and economic resources. To accomplish this aim, analysis of the risk factors related to knee OA progression is necessary to make specific and targeted efforts at prevention.
The risk factors of OA have been studied extensively and various factors including age, genes, sex, hormones, biomechanics, and local environment appear to have explicit relevance to the occurrence of OA. The progression of OA is also influenced by various factors. Generally, the systematic factors include age, race, and heredity which influence susceptibility to OA and local factors including weight, biomechanics, and local environment effect progression of OA. Thus, the synergistic effect of systematic and local factors influence OA progression.
However, there is still a lack of information about the impact of each risk factor for predicting progression of primary knee OA. To our knowledge, the first accepted model of knee OA progression risk factors was developed by Zhang et al. in 2011,[6] yet there has been no large-scale cohort studies or databases established in China according to a rapid review of Medline, Embase, SCI, CINAHL, BIOSIS, Cochrane database, CNKI and Wanfang databases. In contrast, large-scale databases have already contributed greatly to preventive treatment for cancer and neurological, endocrine, and cardiovascular disease. [7] [8] [9] [10] [11] [12] [13] [14] Moreover, assessment of prevention and treatment techniques using large-scale databases have a decided impact on health economic policy. [15] In conclusion, it is of great importance to establish a cohort of patients with primary knee OA, in order to follow the progression of primary knee OA, analyse related risk factors, and develop a predictive model for meaningful early prevention of primary knee OA progression. Therefore, the objectives of this study are to:
1. Develop a cohort of knee OA patients to collect baseline and knee OA progression data.
2. Analyse progression risk factors associated with knee OA and develop a risk assessment model.
3. Verify risk prediction ability of the model using both internal and external validation.
METHODS AND ANALYSIS Participants and outcomes
Study setting This study is a multicentre, prospective cohort study of people with knee OA at early stages living in Beijing, sponsored by the Beijing Municipal Science & Technology Commission, located in Beijing, China. There are five clinical centres participating in the study including Peking University Third Hospital, Peking University First Hospital, Peking University People's Hospital, Beijing Friendship Hospital, and China-Japan Friendship Hospital. Sample size estimate
The proportion of primary knee arthritis progression during the study was assumed to be 15% based on literature reports, and there are 16 predictive factors included in, which were confirmed by most of the studies. According to the multivariable Logistic regression model sample size estimation method,16×15= 240 cases of knee OA progression are needed, so the total number of cases by final follow up should be 240÷15%=1600 cases. Considering the possibilities of loss of follow-up, the sample size was expanded to 1.2 times. Therefore, the estimated sample size is 2000 cases. Study population and eligibility Recruitment of a baseline cohort of 2000 participants will be conducted between December 2017 and November 2018. The participants will be followed up at 12 months, 24 months, 30 months or 36 months, depending on the date of recruitment (Table 1) . 
Gait analysis data X X X "X" indicates that the procedure is carried out.
Eligibility criteria Inclusion criteria was defined by: diagnosis of primary knee OA based on the 2007 revised of diagnostic criteria by the Chinese Medical Association Orthopaedic Branch (Table  2 ) and patients with a registered Beijing residence or permanent resident population in Beijing. Patients were excluded based on the following criteria: knee joint pain caused by diseases other than knee OA (infection, hip joint disease, lumbar disease, etc.); secondary knee OA (trauma, rheumatoid arthritis, ankylosing spondylitis, etc.); presence of severe internal medicine disease (American Society of Anaesthesiologists' classification score ≥3); inability to accomplish three years follow-up, and; refusal to sign the informed consent form. 
Special measures
This study will also include 3 new techniques to predict the progression of knee OA: functional magnetic resonance imaging (MRI), [16] [17] [18] type II collagen C-terminal peptide (CTX-II) biomarker, [19] [20] [21] and gait analysis. [22, 23] These techniques are not widely used for this purpose, but research shows that they have potential to be important predictors.
Routine and functional MRI scans will be performed on knee OA subjects at Peking University Third Hospital and China-Japan Friendship Hospital. The scanning device is a General Electric Company (GE, U.S.) MR scanner (field strength 3.0T). Routine scans include sagittal proton density weighted image (PDWI), T1 weighted image, coronal PDWI and axial PDWI. Functional imaging includes sagittal T2-mapping and T1ρ. The specific method for obtaining knee cartilage measurements will be to use post-processing functional imaging to obtain pseudo-colour maps to identify the degree of cartilage damage in different areas, delineate the region of interest, and measure the T2 and T1ρ values. The obtained knee cartilage measurements will be analysed after the subjects have completed all follow-up examinations.
In this study, CTX-II, which is the most concerning type of cartilage conversion biomarker, was selected for detecting progression of knee joint OA. To reduce the burden on participants and research convenience, urine samples will be used for CTX-II analysis by enzyme-linked immunosorbent assay (ELISA). Trained laboratory researchers will centrifuge the urine sample within 24 hours, take 1-2 mL of the supernatant, and deliver it to the orthopaedic clinical laboratory of Peking University First Hospital for ELISA kit analysis. If the sample cannot be delivered within 24 hours, it will be stored in a low temperature refrigerator until delivered.
The gait and related kinetic parameters of the subjects will be measured by using a 3-dimensional gait analyser. The pace, step frequency, and step size of the subjects will be observed, the duration of the lower limb support period and the percentage of support period will be recorded, and the knee adduction moment will be calculated to assess medial compartment load. Gait analysis will be carried out in the orthopaedic laboratory of Peking University Third Hospital.
Outcome measures
Patients will be monitored through follow-up visits to the research hospitals. The primary outcome measure of this study is a comprehensive outcome index, which will be The WOMAC score will be evaluated by questionnaire which includes 5 questions concerned with pain, 2 questions related to joint stiffness, and 17 questions about difficulties with completing daily activities. Each question contains five grades (0=none, 4=severe) and the total score range is 0-20 points for pain, 0-8 points for stiffness, and 0-96 points for daily living ability. The higher the WOMAC score, the worse the corresponding state.
All the participants will get a radiological examination of the knee joint (anteroposterior and lateral film) and will be filmed at knee extension weight-bearing position. This study will use the same K-L classification as the Beijing Osteoarthritis Study, [24, 25] which Kellgrenet al. [26] proposed in 1957. K-L classification ≥ 2 is defined as imaging osteoarthritis. Criteria to define patellofemoral imaging bone arthritis are as follows: Grade 0=no radiographic features of OA are present; Grade 1=doubtful joint space narrowing (JSN) and possible osteophytic lipping; Grade 2=definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph; Grade 3=multiple osteophytes, definite JSN, sclerosis, possible bony deformity; Grade 4=large osteophytes, marked JSN, severe sclerosis and definite bony deformity.
The outcome indicator for this study is knee OA progression, which is defined as any of the following 3 at the 30-month follow-up point:
1. More than 2 on WOMAC score progress in 1 follow-up period (12 months). 2. K-L graded follow-up period ≥1 grade compared with baseline. 3. Surgical intervention (arthroscopy, osteotomy, single ankle replacement, patellofemoral joint replacement or total knee arthroplasty).
Study timeline
Screening and enrollment
The screening of potential participants will be conducted by an orthopaedic surgeon at each clinical centre to assess the eligibility for the study according to the inclusion and exclusion criteria. When eligible, subjects will be informed to participate during a meeting in the hospital. During the meeting, they will receive the study protocol which also contains answers to common questions and they will also be verbally informed by trained research personnel regarding the nature and purpose of the study, their rights to quit the study at any time, and given time to decide whether or not to participate. After that, study participants will be required to sign a written informed consent.
Baseline visit
Once the written informed consent is obtained, the following information will be obtained:
1. Demographic information 2. Risk factors 3. Intervention factors 4. WOMAC score 5. X-Ray (anteroposterior and lateral film) The study will develop a relevant case report form (CRF) based on the research plan. Trained researchers will load the data into the case report form in a timely, complete, and accurate manner based on the original observation records of the research subjects. Then, the questionnaire will be reviewed and signed by an audit team and sent to the clinical research data administrator. Data entry will be done by two administrators using two computers independently and the data will be compared twice. Problems found during the entry or comparison will be relayed to the inspector in a timely manner, and the researcher will be asked to explain. Questions and answers will be noted on a question form and kept for future reference.
Data verification and management
After all CRF are entered and verified, the data manager will run a database check report, which includes the completion of the study (including the list of shedding), the inclusion/exclusion criteria, the integrity inspection, the logical consistency inspection, outlier data inspection, time window inspection, intervention inspection, adverse event inspection, etc.
At the review meeting, the main investigator, the representative of the collaboration unit, the inspector, the data administrator, and the statistician will decide on the issues raised in the informed consent form and the database inspection report to write the audit report. The database will be locked at the same time.
Data archiving
After data entry and verification of the CRF are completed as required, it will be archived in the order of number for verification. Electronic data files include databases, inspection programs, analysis programs, analysis results, codebooks, and documentation. Data will be stored in separate categories, and multiple backups will be stored on different disks or recording media for safekeeping in case of loss or damage. All the original files will be kept for a period of time according to corresponding regulations. Quality control Standardized training was conducted for all participating surgeons and radiologist regarding protocol for the CRF, physical examination, imaging examination, and all other data collection and storage.. In addition, all data was checked by research staff in our team, to make sure all data are reliable.
Statistical methods
The demographic characteristics, general conditions, risk factors, and intervention factors will be described by using the general statistical description method according to the distribution of the data. Nested case-control analysis will be performed and the subjects will be divided into knee OA progression group and non-progression group based on WOMAC score and imaging K-L grade. The differences of the demographic characteristics risk factors and intervention factors between the two groups will be compared. Several statistical methods will be used to establish the risk prediction model of knee osteoarthritis progression, including logistic regression models, discriminant analysis, classification decision trees, etc. K-fold cross validation will be performed to select the best prediction model based on the Cindex of these prediction models. The external validation will use the pre-established knee osteoarthritis cohort data to determine the accuracy of the established model.
PATIENT AND PUBLIC INVOLVEMENT
Although patients were not explicitly involved in the development of the research questions, design, recruitment or conduct of this study, the research question and outcome measures are based on many years of clinical experience between all the authors. The participants will be encouraged to give feedback about their experience to their clinicians, who are part of the research team.
ETHICS AND DISSEMINATION
Peking University Third Hospital Medical Science Research Ethics Committee has approved the protocol [version 1.0 (2017-5-20) ] (IRB00006761-M2017127) which is registered on the Chinese Clinical Trial Registry (http://www.chictr.org.cn/index.aspx) under number ChiCTR-ROC-17013790. The study will be conducted in accordance with the principles of the Declaration of Helsinki (2013 version). Written informed consent will be obtained from study participants and all collected information will be treated as confidential. Results of this study will be available through publication in peer-reviewed journals and at national or international conferences. In addition, results will be disseminated to all participants via "group chat" of the social software "WeChat".
DISCUSSION
The study is going to establish a study cohort of knee OA, follow-up the progression of knee OA, and analyse the relevant risk factors, so as to establish a predictive model for knee OA progression and outcome, which will be of great value for the early prevention and treatment of primary knee OA. To date, the research on the progression of primary knee OA has revealed the influencing factors, but the importance of each influencing factor is still unclear. We still cannot evaluate the progression risk based on the patient's lifestyle and living At present, there is a lack of mature and generally acknowledged risk prediction model for primary knee OA. The arthritis progression model study proposed by Zhang et al. 5 in 2011 was based on 99 cases and 179 control groups. However, the scale of the study was relatively small, and the model's ability to go through external validation was poor (AUC=0.52). Additionally, the model failed to assess the risk of biomarker or cartilage function and to predict the progression of knee OA on a mechanism level.
To improve the accuracy of the prediction model, we plan to use the classification decision tree, discriminant analysis, and other methods to establish a prediction model and use the K-fold cross-validation method to select the best prediction model. The original sample will be randomly divided into k equal sized subsamples. Of the k subsamples, a single subsample will be retained as the validation data for testing the model, and the remaining k-1 subsamples will be used as training data. The cross-validation process will then be repeated k times, with each of the k subsamples used exactly once as the validation data by comparing the C-index between different prediction models. This will enable to select a more accurate prediction model. This method of cross-validation is relatively mature and efficient, and will help to guide the selection of the optimal prediction model in this study. In addition, we will use an external cohort to validate our model. The database of 1,294 patients with knee OA is established by the Peking University People's Hospital in Zhaoquanying Town Health Centre in Beijing.
To improve the sensitivity of the study, we will perform the following research design. We will use functional MRI, biological marker evaluation, and gait analysis as secondary outcome indicators. Functional MRI will serve as a model observation index with good sensitivity and specificity, because it allows direct observation and evaluation of the cartilage, the most fundamental pathological structure of OA; the detection of related molecular biological markers (type II collagen C-terminal peptide, u-CTX-II) and three-dimensional gait analysis will help observe the progression of OA from the viewpoint of molecular biology and biomechanics. These not only have the theoretical advantage of early and accurate assessment of the development of OA, but are also of great significance for the further exploration of relevant mechanisms. This study also intends to combine the WOMAC score, KL grade imaging, and clinical outcome assessment to evaluate knee OA progression. This comprehensive outcome index is expected to improve the sensitivity of the model within a limited follow-up time.
The study has the following limitations: 1. Short study time: the duration of this study is limited at 3 years because of the project requirements; hence, it might be difficult to observe the actual progression of OA within this limited time period. 2. Insufficient sample size: the sample size of this study design is only 2000, which is relatively small for establishing a progression model. In response to these two limitations, we will use unique statistical methods and outcome indicators to improve the accuracy and sensitivity of the research. Besides, we plan to continue to enrol new patients after the 3-year period to expand the 
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